Replies to post #3032 on Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

The publication of the results is recent but the failure of the trial is old news
Shionogi has a prevention trial that is nearly fully enrolled for ensitrelvir

Oops, my mistake. Thanks for reminding me. If Shionogi's trial fails, that might make EDP-235 a drug of some interest, especially since Covid is not going away.